193 related articles for article (PubMed ID: 22101269)
21. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks.
Banerjee S; Sengupta K; Saxena NK; Dhar K; Banerjee SK
Mol Cancer Res; 2005 Mar; 3(3):151-62. PubMed ID: 15798095
[TBL] [Abstract][Full Text] [Related]
22. [The siRNA-mediated silencing of Bmi-1 promotes apoptosis and inhibits invasion of MCF-7 breast cancer cells].
Deng X; Wu X; Weng H; Song F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1036-40. PubMed ID: 27412932
[TBL] [Abstract][Full Text] [Related]
23. MYB suppresses differentiation and apoptosis of human breast cancer cells.
Drabsch Y; Robert RG; Gonda TJ
Breast Cancer Res; 2010; 12(4):R55. PubMed ID: 20659323
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.
Drabsch Y; Hugo H; Zhang R; Dowhan DH; Miao YR; Gewirtz AM; Barry SC; Ramsay RG; Gonda TJ
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13762-7. PubMed ID: 17690249
[TBL] [Abstract][Full Text] [Related]
25. c-MYB and TGFβ: EMT's dynamic duo in breast cancer.
Sala A
Cell Cycle; 2012 Jan; 11(1):17. PubMed ID: 22186784
[No Abstract] [Full Text] [Related]
26. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
27. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
Li Y; Jin K; van Pelt GW; van Dam H; Yu X; Mesker WE; Ten Dijke P; Zhou F; Zhang L
Cancer Res; 2016 Jun; 76(11):3364-75. PubMed ID: 27197202
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.
Cherlet T; Murphy LC
Mol Cell Biochem; 2007 Dec; 306(1-2):33-42. PubMed ID: 17660955
[TBL] [Abstract][Full Text] [Related]
29. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
[TBL] [Abstract][Full Text] [Related]
30. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
31. ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition.
Yin L; Castagnino P; Assoian RK
Cancer Res; 2008 Feb; 68(3):800-7. PubMed ID: 18245481
[TBL] [Abstract][Full Text] [Related]
32. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y
Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007
[TBL] [Abstract][Full Text] [Related]
33. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
34. Construction of SIRT1 gene shRNA lentivirus vector and its effect on the proliferation of breast cancer cells.
Yue Y; He L; Tian M; Li X
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):204-210. PubMed ID: 32538772
[TBL] [Abstract][Full Text] [Related]
35. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status.
Feng X; Zhang M; Wang B; Zhou C; Mu Y; Li J; Liu X; Wang Y; Song Z; Liu P
J Exp Clin Cancer Res; 2019 Aug; 38(1):361. PubMed ID: 31419991
[TBL] [Abstract][Full Text] [Related]
36. RBM38 is involved in TGF-β-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer.
Wu J; Zhou XJ; Sun X; Xia TS; Li XX; Shi L; Zhu L; Zhou WB; Wei JF; Ding Q
Br J Cancer; 2017 Aug; 117(5):675-684. PubMed ID: 28683467
[TBL] [Abstract][Full Text] [Related]
37. Differential effect of growth factors on invasion and proliferation of endocrine resistant breast cancer cells.
Khajah MA; Al Saleh S; Mathew PM; Luqmani YA
PLoS One; 2012; 7(7):e41847. PubMed ID: 22860018
[TBL] [Abstract][Full Text] [Related]
38. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
[TBL] [Abstract][Full Text] [Related]
39. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
Arima Y; Inoue Y; Shibata T; Hayashi H; Nagano O; Saya H; Taya Y
Cancer Res; 2008 Jul; 68(13):5104-12. PubMed ID: 18593909
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells.
Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G
Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
